Amgen said on Monday its experimental therapy helped patients with advanced gastric cancer live longer when combined with ...

The FDA said risks linked to CAR-T cell therapies can be effectively communicated through existing labeling, including boxed ...

A new medication found to reduce the chance of the most common types of breast cancer recurring will be available to many ...

Boston: TOBY, Inc., a biotech startup advancing non-invasive cancer detection through urine-based volatilomics and Artificial ...

During June, investigators reported new data that has advanced the treatment landscape for lung cancer, including new FDA ...

A potentially life-saving treatment for early-stage breast cancer will become much more affordable for hundreds of ...

Restricted availability under an FDA-mandated drug safety program has limited the reach of CAR-T cell therapies for certain ...

Scientists discovered a cancer-fighting compound in mold from ancient tombs, revealing a powerful new drug against leukemia.

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating ...

Specifically, the FDA removed the Risk Evaluation and Mitigation Strategy (REMS) program requirements from two BCMA-directed CAR T-cell therapies for multiple myeloma — ciltacabtagene autoleucel ...

Shares of Alembic Pharmaceuticals climbed over 12% after the company secured USFDA approval for its generic Doxorubicin ...

Karen Knudsen is leading Sean Parker’s cancer immunotherapy incubator where philanthropy and venture capital meet.